Literature DB >> 4042796

Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota.

M S Dwyer, L J Melton, D J Ballard, P J Palumbo, J C Trautmann, C P Chu.   

Abstract

Among the 1135 Rochester residents discovered to have diabetes in the period 1945-69, the prevalence of retinopathy was 2.6% at the time of initial diagnosis. Among those free of retinopathy at diagnosis of diabetes, the subsequent incidence of any retinopathy was 17.4 per 1000 person-years and for proliferative retinopathy alone was 1.6 per 1000 person-years, based on 12,000 person-years of follow-up. The incidence rate of retinopathy was almost three times greater among residents with insulin-dependent (IDDM) than with non-insulin-dependent diabetes (NIDDM); however, the actual number of retinopathy cases was over four times greater among the more numerous residents with NIDDM. By 20 yr after diagnosis of diabetes, the cumulative incidence of retinopathy approached 70% among IDDM subjects and was 30% and 36%, respectively, among the obese and nonobese NIDDM residents. The epidemiologic patterns for proliferative retinopathy were qualitatively similar to those for nonproliferative retinopathy. The risk of blindness was greater among those with proliferative than with nonproliferative retinopathy but was substantial even for those without retinopathy. Most blindness was caused by factors other than isolated diabetic retinopathy.

Entities:  

Mesh:

Year:  1985        PMID: 4042796     DOI: 10.2337/diacare.8.4.316

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  19 in total

1.  Prevalence of Diabetic Retinopathy in Western Indian Type 2 Diabetic Population: A Hospital - based Cross - Sectional Study.

Authors:  Piyush Rameshchandra Ramavat; Manish Rameshchandra Ramavat; Balaji Wasudeo Ghugare; Rohini G Vaishnav; Manjiri Uttam Joshi
Journal:  J Clin Diagn Res       Date:  2013-06-01

2.  Cultured retinal capillary pericytes die by apoptosis after an abrupt fluctuation from high to low glucose levels: a comparative study with retinal capillary endothelial cells.

Authors:  W Li; X Liu; M Yanoff; S Cohen; X Ye
Journal:  Diabetologia       Date:  1996-05       Impact factor: 10.122

3.  The 25-year incidence of visual impairment in type 1 diabetes mellitus the wisconsin epidemiologic study of diabetic retinopathy.

Authors:  Ronald Klein; Kristine E Lee; Ronald E Gangnon; Barbara E K Klein
Journal:  Ophthalmology       Date:  2009-10-31       Impact factor: 12.079

4.  A community-based follow-up study on diabetic retinopathy among type 2 diabetics in Kinmen.

Authors:  Tao-Hsin Tung; Shih-Jen Chen; Jorn-Hon Liu; Fenq-Lih Lee; An-Fei Li; Mong-Ping Shyong; Pesus Chou
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

5.  Clinical and metabolic factors associated with the blood retinal barrier permeability in insulin dependent diabetes mellitus without retinopathy.

Authors:  J M Benitez del Castillo; A Castillo; P C Fernandez; J Garcia Sanchez
Journal:  Doc Ophthalmol       Date:  1993       Impact factor: 2.379

6.  Prevention of blindness by screening for diabetic retinopathy: a quantitative assessment.

Authors:  T E Rohan; C D Frost; N J Wald
Journal:  BMJ       Date:  1989-11-11

7.  Ultrastructural alterations in capillaries of the diabetic hypertensive rat retina: protective effects of ACE inhibition.

Authors:  A A Dosso; E Rungger-Brändle; P M Leuenberger
Journal:  Diabetologia       Date:  2004-07-09       Impact factor: 10.122

Review 8.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

Review 9.  Diabetes-related eye disorders.

Authors:  R J Sanders; M R Wilson
Journal:  J Natl Med Assoc       Date:  1993-02       Impact factor: 1.798

10.  Presence of diabetes related complication at the time of NIDDM diagnosis: an important prognostic factor.

Authors:  A Ruigómez; L A García Rodríguez
Journal:  Eur J Epidemiol       Date:  1998-07       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.